Anteris Technologies Global Corp. — Board/Management Information 2012

Apr 2, 2012

ASX ANNOUNCEMENT

==> picture [595 x 113] intentionally omitted <==

Resignation of Director

BRISBANE, Australia, 3 April 2012

Allied Healthcare Group Limited (“Allied”) today announced that Mr Robert Towner has resigned as a non-executive member of Allied’s Board of Directors effective immediately.

The board and management of Allied Healthcare Group would like to thank Mr Towner for his support and efforts, particularly during the recent merger between bioMD and Allied Healthcare Group, which has now been fully completed with the two companies now fully integrated. The Company wishes Mr Towner all the best for his future endeavours.

Since the merger last year Allied Healthcare Group has made significant progress on several programs and is looking forward to the initiation of the Coridon Phase I trial later this year and the progression of the Celxcel technology through the regulatory approval process towards marketing approval.

The Company will look to strengthen its board in the near future.

For more information, please contact:

Dr Julian Chick, Chief Operating Officer Allied Healthcare Group Tel: +61 3 9620 5454

Media: Paul Dekkers Buchan Consulting +61 2 9237 2800 pdekkers@buchanwe.com.au

About Allied Healthcare Group Limited

Allied Healthcare Group Limited (ASX: AHZ) is a diversified healthcare company focused on investing in and developing next generation technologies with world class partners, acquiring strategic assets to grow its product and service offerings and expanding revenues from its existing profitable medical sales and distribution business. The Company has assets from Research & Development through Clinical Development as well as Sales, Marketing and Distribution.

Allied Healthcare Group is in the process of commercializing its innovative tissue engineering technology for regenerative medicine and is a major investor in Brisbane based Coridon Pty Ltd, led by Professor Ian Frazer developing next generation vaccines for global markets.

Further information on the Company can be found on www.alliedhealthcaregroup.com.au.

ABN 35 088 221 078 Level 1, 197 Adelaide Terrace Perth Western Australia 6000 PO Box 6879 East Perth Western Australia 6892 T +61 (0)8 9266 0100 F +61 (0)8 9266 0199 E info@alliedhealthcaregroup.com.au

www.alliedhealthcaregroup.com.au

Appendix 3Z Final Director’s Interest Notice

Rule 3.19A.3

Appendix 3Z

Final Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Allied Healthcare Group Limited ABN 35 088 221 078

We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director	Robert Towner
Date of last notice	1 December 2011
Date that director ceased to be director	2 April 2012

Part 1 – Director’s relevant interests in securities of which the director is the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

5,687,500 ordinary fully paid shares

• See chapter 19 for defined terms.

Appendix 3Z Page 2

11/3/2002

Appendix 3Z Final Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

	Name of holder & nature of interestNote: Provide details of the circumstances givingrise to the relevant interest(i)Austin 4 Pty Limited(ii)Mandolin Pty Limited	Number & class of securities1,809,492 Ordinary fully paid shares13,615,000 Ordinary fully paid shares

Part 3 – Director’s interests in contracts

Detail of contract Nature of interest Name of registered holder (if issued securities) No. and class of securities to which interest relates

• See chapter 19 for defined terms.

Appendix 3Z Page 3

11/3/2002